Early versus late acute kidney injury among patients with COVID-19—a multicenter study from Wuhan, China

Suyuan Peng,Huai-Yu Wang,Xiaoyu Sun,Pengfei Li,Zhanghui Ye,Qing Li,Jinwei Wang,Xuanyu Shi,Liu Liu,Ying Yao,Rui Zeng,Fan He,Junhua Li,Shuwang Ge,Xianjun Ke,Zhibin Zhou,Erdan Dong,Haibo Wang,Gang Xu,Luxia Zhang,Ming-Hui Zhao
DOI: https://doi.org/10.1093/ndt/gfaa288
IF: 7.1857
2020-12-01
Nephrology Dialysis Transplantation
Abstract:Abstract Background Acute kidney injury (AKI) is an important complication of coronavirus disease 2019 (COVID-19), which could be caused by both systematic responses from multi-organ dysfunction and direct virus infection. While advanced evidence is needed regarding its clinical features and mechanisms. We aimed to describe two phenotypes of AKI as well as their risk factors and the association with mortality. Methods Consecutive hospitalized patients with COVID-19 in tertiary hospitals in Wuhan, China from 1 January 2020 to 23 March 2020 were included. Patients with AKI were classified as AKI-early and AKI-late according to the sequence of organ dysfunction (kidney as the first dysfunctional organ or not). Demographic and clinical features were compared between two AKI groups. Their risk factors and the associations with in-hospital mortality were analyzed. Results A total of 4020 cases with laboratory-confirmed COVID-19 were included and 285 (7.09%) of them were identified as AKI. Compared with patients with AKI-early, patients with AKI-late had significantly higher levels of systemic inflammatory markers. Both AKIs were associated with an increased risk of in-hospital mortality, with similar fully adjusted hazard ratios of 2.46 [95% confidence interval (CI) 1.35–4.49] for AKI-early and 3.09 (95% CI 2.17–4.40) for AKI-late. Only hypertension was independently associated with the risk of AKI-early. While age, history of chronic kidney disease and the levels of inflammatory biomarkers were associated with the risk of AKI-late. Conclusions AKI among patients with COVID-19 has two clinical phenotypes, which could be due to different mechanisms. Considering the increased risk for mortality for both phenotypes, monitoring for AKI should be emphasized during COVID-19.
urology & nephrology,transplantation
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore two clinical phenotypes of acute kidney injury (AKI) in patients with Coronavirus Disease 2019 (COVID - 19) and their risk factors, and analyze the association between these phenotypes and in - hospital mortality. Specifically, the researchers focused on the following points: 1. **Describe two AKI phenotypes**: According to the order of organ dysfunction, AKI was divided into two phenotypes: early (AKI - early) and late (AKI - late). AKI - early was defined as AKI that occurred before any other organ dysfunction; while AKI - late referred to AKI in all other cases. 2. **Analyze risk factors**: The researchers explored the risk factors for different AKI phenotypes, including hypertension, diabetes, cardiovascular diseases, chronic kidney disease (CKD), levels of inflammatory markers, etc. 3. **Evaluate the relationship with mortality**: The researchers analyzed the relationship between AKI and all - cause mortality during hospitalization through a multivariate Cox proportional - hazards model to determine whether AKI increased the death risk in COVID - 19 patients. ### Main findings - **Incidence of AKI**: Among 4,020 laboratory - confirmed COVID - 19 patients, a total of 285 (7.09%) were diagnosed with AKI, of which 91 were AKI - early and 194 were AKI - late. - **Risk factors**: - For AKI - early, the only independently associated risk factor was hypertension, with an adjusted relative risk ratio (RRR) of 2.29 (95% CI 1.12 - 4.67). - For AKI - late, the independently associated risk factors included age, CKD, and high levels of inflammatory markers (hs - CRP and ferritin), with adjusted RRRs of 1.05 (95% CI 1.04 - 1.07), 4.21 (95% CI 1.67 - 10.64), 7.81 (95% CI 2.72 - 22.44), and 4.59 (95% CI 1.97 - 10.68), respectively. - **Relationship with mortality**: Compared with non - AKI patients, AKI patients showed a higher death risk in both unadjusted and adjusted analyses. In particular, the AKI - late group had a higher death risk, with an adjusted hazard ratio (HR) of 3.09 (95% CI 2.17 - 4.40), while the AKI - early group had an HR of 2.46 (95% CI 1.35 - 4.49). ### Conclusion This study shows that AKI in COVID - 19 patients has two different clinical phenotypes, and both phenotypes are associated with a higher in - hospital mortality. Therefore, during the COVID - 19 epidemic, it is particularly important to monitor the occurrence of AKI, especially in terms of early identification and management.